| A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres SS D’Souza, JA Faraj, PP DeLuca Aaps Pharmscitech 6, E553-E564, 2005 | 106 | 2005 |
| Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system JA Faraj, R Dorati, A Schoubben, D Worthen, F Selmin, Y Capan, K Leung, ... Aaps Pharmscitech 8, E177-E185, 2007 | 76 | 2007 |
| Hydrolysis of leucine enkephalin in the nasal cavity of the rat—a possible factor in the low bioavailability of nasally administered peptides A Hussain, J Faraj, Y Aramaki, JE Truelove Biochemical and biophysical research communications 133 (3), 923-928, 1985 | 69 | 1985 |
| Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the oral cavity DH Na, J Faraj, Y Capan, KP Leung, PP DeLuca Pharmaceutical research 24, 1544-1550, 2007 | 66 | 2007 |
| Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: preformulation study DH Na, J Faraj, Y Capan, KP Leung, PP DeLuca Journal of Controlled Release 107 (1), 122-130, 2005 | 66 | 2005 |
| IVIVC from long acting olanzapine microspheres S D'Souza, JA Faraj, S Giovagnoli, PP DeLuca International journal of biomaterials 2014, 2014 | 63 | 2014 |
| Development of risperidone PLGA microspheres S D’Souza, JA Faraj, S Giovagnoli, PP DeLuca Journal of Drug Delivery 2014, 2014 | 50 | 2014 |
| Mechanism of nasal absorption of drugs. III: nasal absorption of leucine enkephalin JA Faraj, AA Hussain, Y Aramaki, K Iseki, M Kagoshima, LW Dittert Journal of pharmaceutical sciences 79 (8), 698-702, 1990 | 41 | 1990 |
| In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms S D’Souza, JA Faraj, S Giovagnoli, PP DeLuca Progress in biomaterials 3, 131-142, 2014 | 35 | 2014 |
| Microsphere delivery of Risperidone as an alternative to combination therapy S D’Souza, J Faraj, P DeLuca European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 631-639, 2013 | 35 | 2013 |
| Antimicrobial peptides for plaque control KP Leung, JJ Abercrombie, TM Campbell, KD Gilmore, CA Bell, JA Faraj, ... Advances in Dental Research 21 (1), 57-62, 2009 | 32 | 2009 |
| A short term quality control tool for biodegradable microspheres S D’Souza, JA Faraj, R Dorati, PP DeLuca AAPS PharmSciTech 15, 530-541, 2014 | 30 | 2014 |
| Enhanced degradation of lactide-co-glycolide polymer with basic nucleophilic drugs S D’Souza, JA Faraj, R Dorati, PP DeLuca Advances in Pharmaceutics 2015, 2015 | 29 | 2015 |
| Mechanism of nasal absorption of drugs. IV: Plasma levels of radioactivity following intranasal administration of [3H] leucine enkephalin JA Faraj, AA Hussain, Y Aramaki, K Iseki, M Kagoshima, LW Dittert Journal of pharmaceutical sciences 79 (9), 768-770, 1990 | 16 | 1990 |
| Preparation, characterization, and in vivo evaluation of olanzapine poly (d, l-lactide-co-glycolide) microspheres S D'Souza, JA Faraj, S Giovagnoli, PP DeLuca Journal of Pharmaceutics 2013, 2013 | 15 | 2013 |
| Development of a sustained antiplaque and antimicrobial chewing gum of a decapeptide AM Al-Ghananeem, KP Leung, J Faraj, PP DeLuca AAPS PharmSciTech 18, 2240-2247, 2017 | 12 | 2017 |
| Evaluation of the Wheat Germ Oil Topical Formulations for Wound Healing Activity in Rats. R Zakaria, J Faraj Pakistan journal of biological sciences: PJBS 24 (6), 706-715, 2021 | 7 | 2021 |
| Unstirred Water Layer Effects on Biodegradable Microspheres S D’Souza, JA Faraj, PP DeLuca Advances in Pharmaceutics 2015, 2015 | 5 | 2015 |
| Fulvestrant formulations JA Faraj US Patent 9,271,990, 2016 | 4 | 2016 |
| In vitro characterization of six month dosage forms for a GnRH antagonist S D’Souza, S Murty, JA Faraj, PP DeLuca Advances in pharmaceutics 2014, 2014 | 3 | 2014 |
